North America's Market Leadership
North America holds a leading position in the global gamma knife market, driven by its robust healthcare infrastructure, high healthcare expenditure, and a strong emphasis on technological adoption. The United States, in particular, is a major market due to the high number of advanced neurosurgical centers, favorable reimbursement policies for radiosurgery, and a high prevalence of neurological disorders. The region is also home to key market players and a significant number of ongoing clinical trials related to neurosurgical technologies.
The strong presence of these factors creates a fertile ground for the adoption of Gamma Knife technology. Additionally, a high level of patient awareness and a cultural preference for minimally invasive procedures further contribute to the market's dominance in the region. While other regions are growing, North America's established ecosystem of research, innovation, and healthcare delivery makes it a key player in the global market.